News Medical on MSN3mon
Future directions and challenges in harnessing NK cells against Acute Myeloid Leukemiaimpaired maturation, and the presence of an immunosuppressive tumor microenvironment. Additionally, AML cells can evade NK ...
The outcomes of treatment with gemtuzumab ozogamicin compared with those of conventional chemotherapy for relapse of acute myelogenous leukemia (AML) were studied. The gemtuzumab ozogamicin group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback